Dihydroxy Diketo Atorvastatin IMpurity
CAS1046118-44-8
Dihydroxy Diketo Atorvastatin IMpurity (CAS 1046118-44-8, C26H24FNO5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 1046118-44-8
- Formula
- C26H24FNO5
- Mol. weight
- 449.47 g/mol
Chemical Specifications
Identifiers
| CAS number | 1046118-44-8 |
|---|---|
| Product name | Dihydroxy Diketo Atorvastatin IMpurity |
| Chinese name | 二羟基阿托伐他汀二酮杂质 |
| Synonyms | Dihydroxy Diketo Atorvastatin IMpurity |
| Chinese synonyms | 二羟基阿托伐他汀二酮杂质; 二羟基二酮阿托伐他汀杂质 |
| Molecular formula | C26H24FNO5 |
| Molecular weight | 449.47 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of Dihydroxy Diketo Atorvastatin IMpurity?
The CAS Registry Number of Dihydroxy Diketo Atorvastatin IMpurity is 1046118-44-8. Dihydroxy Diketo Atorvastatin IMpurity is also known as Dihydroxy Diketo Atorvastatin IMpurity.
What is the molecular formula and molecular weight of Dihydroxy Diketo Atorvastatin IMpurity?
The molecular formula of Dihydroxy Diketo Atorvastatin IMpurity is C26H24FNO5, and its molecular weight is 449.47 g/mol.
How can I request a quotation for Dihydroxy Diketo Atorvastatin IMpurity?
Send an inquiry for Dihydroxy Diketo Atorvastatin IMpurity (CAS 1046118-44-8) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for Dihydroxy Diketo Atorvastatin IMpurity
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.